Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Scripps Research Institute | 8 |
| 2 | Daiichi Sankyo Co Ltd | 6 |
| 3 | Tanabe Pharma Corp | 5 |
| 4 | The University of Texas System | 5 |
| 5 | Ube Corp | 5 |
| 6 | University of Alabama System | 5 |
| 7 | Icagen Inc | 4 |
| 8 | Innoviva Inc | 4 |
| 9 | Sanofi SA | 3 |
| 10 | Torrent Pharmaceuticals Ltd | 3 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 63 |
| 2 | A61P | Therapeutic activity (drug indications) | 29 |
| 3 | Y10S | Cross-reference (legacy) | 19 |
| 4 | C07D | Heterocyclic compounds | 13 |
| 5 | G01N | Investigating / analysing materials | 13 |
| 6 | C07K | Peptides | 9 |
| 7 | B82Y | Nanotechnology | 8 |
| 8 | A61Q | Cosmetics, personal care | 7 |
| 9 | A61M | Devices for introducing media into the body | 4 |
| 10 | C07H | Sugars and derivatives | 4 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| DHA-pharmaceutical agent conjugates of taxanes | 1998 | Daiichi Sankyo Co Ltd | 360 |
| Modified release composition for highly soluble drugs | 2012 | Torrent Pharmaceuticals Ltd | 164 |
| Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | 2012 | Torrent Pharmaceuticals Ltd | 160 |
| Attaching agents to tissue with transglutaminase and a transglutaminase substrate | 2001 | 171 | |
| DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF | 2010 | Monash University | 69 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Cristobalina Mayorga | Hospital Materno-Infantil | 14 |
| 2 | Marı́a José Torres | Hospital Doctor José Molina Orosa | 12 |
| 3 | M. Blanca | Hospital Doctor José Molina Orosa | 11 |
| 4 | C. Juárez | Hospital Doctor José Molina Orosa | 7 |
| 5 | Hai–Ling Qiao | Zhengzhou University | 6 |
| 6 | Rafael Suau | Universidad de Málaga | 4 |
| 7 | Xin Tian | Zhengzhou University | 4 |
| 8 | Tahía D. Fernández | Hospital Doctor José Molina Orosa | 4 |
| 9 | E. Pérez | Universidad de Málaga | 4 |
| 10 | Miguel Blanca | Hospital Doctor José Molina Orosa | 4 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Heterogeneous T cell responses to β-lactam-modified self-structures are observed in penicillin-allergic individuals | 1995 | 191 | Drug-Induced Adverse Reactions |
| Clinical evaluation of Pharmacia CAP System™ RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy | 2001 | 181 | Asthma and respiratory diseases |
| Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins | 2008 | 177 | Food Allergy and Anaphylaxis Research |
| Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy | 1997 | 166 | Asthma and respiratory diseases |
| The Complex Clinical Picture of β-Lactam Hypersensitivity: Penicillins, Cephalosporins, Monobactams, Carbapenems, and Clavams | 2010 | 141 | Food Allergy and Anaphylaxis Research |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of the benzylpenicilloyl group?
Which organizations hold the most patents mentioning this compound?
What are the primary research topics associated with this compound in published literature?
Who are the most prolific authors publishing on this compound?
What patent technology classifications are most frequently associated with this compound?